Our transcriptome-wide m6A-seq assay, the subsequent validation and functional studies suggest that HK2 and SLC2A1 (GLUT1) are the critical target genes of METTL3 in CRC. This evidence concerns the gene SLC2A1 and colorectal carcinoma.